CLUTCH Trial
CLEVIDIPINE FOR THE ANTIHYPERTENSIVE TREATMENT OF ACUTE INTRACEREBRAL HEMORRHAGE - (CLUTCH)
Trial
Demographics:
USA and Europe
Sponsor:
Zeenat Qureshi Stroke Institutes
Supported by:
Chiesi, USA
Site Recruitment:
Ongoing
Enrollment Target:
1500 patients
Study Type:
Pragmatic, prospective non-randomized cluster study
Study Principal Investigator:
Adnan I. Qureshi, MD
Endovascular Surgical
Neuroradiology program,
University
of Missouri, Columbia, MO, Zeenat Qureshi Stroke Institute, Columbia, MO
Steering Committee Members:
• Joao A. Gomes, MD
FAHA FCCM Head,
Neurointensive care
Associate
Professor
of Neurology, Lerner College of Medicine Cleveland Clinic, Cleveland, OH.
• Ye Alejandro A. Rabinstein, MD
Professor of Neurology, Chair,
Neurocritical Care and Hospital Neurology, Mayo Clinic, Rochester, MN.
• Ali Seifi, MD, FACP, FNCS, FCCM
Professor of Neurosurgery
and Neuro
Critical Care Department of Neurosurgery Director, Neuro Intensive Care Unit
Fellowship
Director, Neuro Critical Care Distinguished Star Educator University of Texas Health
at
San Antonio, TX.
• Prof. Dr. Thorsten Steiner, MME, FESO
FEAN Chefarzt: Klinik für Neurologie,
Varisano Klinikum Frankfurt Höchst Affiliated Professor, Faculty of Health and
Medical Sciences, Universität Copenhagen Chair: Intracerebel Hemorrhage (ICH)
Committee European Stroke Organization (ESO) Wissenschaftlicher Mitarbeiter der
Neurologische Klinik, Universität Heidelberg, Germany.
• Chi-Ren Shyu, Ph.D., FACMI, FAMIΑ
Director, Institute for Data Science and
Informatics Paul K. and Dianne Shumaker Professor, College of Engineering,
University of Missouri, Columbia, MO.
• Fawaz Al-Mufti, MD
Vice Chair of Neurology (Research), Associate
Professor of Neurology, Neurosurgery and Radiology, New York Medical College,
Director of the Neuroendovascular Surgery Fellowship, Director of Neurocritical Care
Unit, Westchester Medical Center at New York Medical College, NY.